Yeah, Steroids Will Totally Ruin Your Life
This image was lost some time after publication. It was pointed out when Yankees Meat Loaf impersonator Jason Giambi admitted to taking steroids in front of the BALCO grand jury that steroids worked out just fine for him. A year after it was confirmed by Giambi was taking steroids, he signed a nine-digit contract with the Yankees. Ask him, in dark hours, if he would do it again. Wouldn't you?
Anyway, a similar, if more understated, story out of Milwaukee over the weekend: Closer Derrick Turnbow, who came out of nowhere to become a bullpen force just last year, signed a three-year, $6.5 million extension with the Brewers.
This is the same Derrick Turnbow who, as an anonymous righthander for the Angels back in 2003, tested positive for steroids right before his major-league breakthrough. Turnbow claimed the positive test was for an over-the-counter drug that was banned by the IOC but not by baseball, and that the whole thing was an accident. Which, while possibly true, is a rather common excuse. Maybe steroids helped Turnbow, maybe they didn't, but no matter what, life has turned out pretty well for the guy. Ask him if, ultimately, he'd do anything different. Would you?
Turnbow Gets Extension [Al's Ramblings] Turnbow Tests Positive For Steroids [Baseball America] He Would Do Anything For Love (But He Won't Do Steroids) [Deadspin]
NBA Best Bets: Expert Picks for Tuesday’s Playoff Action
Top Remaining Veterans Teams Should Target After NFL Draft
Why Top NBA Draft Prospects Aren’t Guaranteed Stars
Top Quarterbacks to Watch for the 2027 NFL Draft
- UFC Vegas 116 Best Bets: Full Card Picks, Props, and Betting Predictions
- Best Betting Picks for Saturday’s NBA Playoff Matchups
- Friday NBA Picks & Predictions: Best Bets for April 24 Playoff Slate
- MLB Best Bets Today: Strikeout Props and Total Plays to Target
- NBA Playoffs Betting Picks: Game 3 Predictions & Best Bets
- NBA Playoff Picks: Rockets vs Lakers & Spurs vs Blazers Best Bets
- MLB Betting Picks Today: Two Expert Picks for Tuesday’s Slate

